Metropolitan Life Insurance Company (MetLife)’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,499
Closed -$11.9K 2380
2022
Q1
$11.9K Sell
3,499
-9,828
-74% -$53.4K ﹤0.01% 2231
2021
Q4
$98.6K Buy
13,327
+5,632
+73% +$40.9K ﹤0.01% 2494
2021
Q3
$61.7K Sell
7,695
-5,361
-41% -$52K ﹤0.01% 2738
2021
Q2
$162K Buy
+13,056
New +$155K ﹤0.01% 2306

Other funds holding AVAH

Metropolitan Life Insurance Company (MetLife)'s AVAH Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aveanna Healthcare (AVAH) in Q2 2022, closing a stake of 3,499 shares — an estimated $11.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AVAH in Q2 2021 and held it in 4 quarters. The position peaked at $162K in Q2 2021. 88 funds tracked by Wall St. Rank hold AVAH as of Q2 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Aveanna Healthcare position as of Q2 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,499 Aveanna Healthcare shares in Q2 2022, an estimated $11.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Aveanna Healthcare in Q2 2021 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Aveanna Healthcare position peaked at $162K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.